Itrizole and alanine aminotransferase increased Patient Reports February 13, 2012

Itrizole Side Effects Report #4714273-9
Itrizole side effect was reported by a Physician from JAPAN on June 28, 2005. Female patient, 45 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, oedema peripheral, white blood cell count decreased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #4543184-7
Itrizole side effect was reported by a Physician from on Dec 20, 2004. Male patient, 69 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bradycardia, gamma-glutamyltransferase increased, hepatic function abnormal, ileus, nausea . Itrizole dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, FAMOTIDINE, NIFEDIPINE, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient recovered.

Itrizole Side Effects Report #4714274-0
Itrizole side effect was reported by a Pharmacist from JAPAN on June 28, 2005. Female patient, 64 years of age, was diagnosed with onychomycosis, constipation , breast cancer , paronychia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ANASTROZOLE, CEFPODOXIME PROXETIL. Patient recovered.

Itrizole Side Effects Report #5044761-X
Itrizole side effect was reported by a Physician from JAPAN on June 27, 2006. Female patient, 60 years of age, was diagnosed with nail tinea, hypertension and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal, hypotension. Itrizole dosage: unknown. During the same period patient was treated with BENIDIPINE HYDROCHLORIDE, CANDESARTAN CILEXETIL. Patient recovered.


Itrizole Side Effects Report #4791823-8
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.

Itrizole Side Effects Report #4791824-X
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.

Itrizole Side Effects Report #5567985-1
Itrizole side effect was reported by a Physician from JAPAN on Dec 14, 2007. Female patient, weighting 81.57 lb, was diagnosed with candida serology positive and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cervix carcinoma, hepatic failure. Itrizole dosage: unknown. During the same period patient was treated with FLOMOXEF, TIENAM. Patient was hospitalized. Patient died on 12/12/2007.

Itrizole Side Effects Report #5655629-X
Itrizole side effect was reported by a Physician from JAPAN on Feb 26, 2008. Female patient, weighting 81.57 lb, was diagnosed with candida serology positive and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cervix carcinoma, hepatic failure. Itrizole dosage: unknown. During the same period patient was treated with FLUMARIN, TIENAM. Patient was hospitalized. Patient died on 12/12/2007.

Itrizole Side Effects Report #5756515-7
Itrizole side effect was reported by a Physician from JAPAN on May 23, 2008. Female patient, weighting 81.57 lb, was diagnosed with candida serology positive and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cervix carcinoma, hepatic failure. Itrizole dosage: unknown. During the same period patient was treated with FLUMARIN, TIENAM. Patient was hospitalized. Patient died on 12/12/2007.


Itrizole Side Effects Report #6089089-4
Itrizole side effect was reported by a Physician from JAPAN on Feb 20, 2009. Female patient, weighting 88.18 lb, was diagnosed with cardiac failure, gastric ulcer, hypertension, sepsis  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood sodium abnormal, blood urea abnormal, gamma-glutamyltransferase increased. Itrizole dosage: unknown. During the same period patient was treated with LASIX, DOGMATYL, NORVASC, MEROPEN. Patient died on 01/13/2009.

Itrizole Side Effects Report #6108768-3
Itrizole side effect was reported by a Physician from JAPAN on Mar 06, 2009. Female patient, weighting 88.18 lb, was diagnosed with febrile neutropenia, cardiac failure, gastric ulcer, hypertension, sepsis  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood sodium abnormal, blood urea abnormal, gamma-glutamyltransferase increased. Itrizole dosage: unknown. During the same period patient was treated with LASIX, DOGMATYL, NORVASC, MEROPEN. Patient died on 01/13/2009.